Guidance for control of parvovirus B19 infection in healthcare settings and the community

Interventions for parvovirus B19 infection need to balance the low risk of infection at a population level with the potential for serious adverse outc ome for particular groups, notably the fetus, people with haemoglobinopathi es and the immunocompromised, This guidance aims to assist the local decisi on-making process to be as evidence-based as the available evidence allows.